Taking GLP-1s appears to alter these areas and change the levels of reward-related neurotransmitters dopamine and glutamate, a review of related studies suggests
You might be a strong contender for semaglutide treatment if your body mass index reaches 30 or more, or 27 with accompanying weight-induced health conditions like hypertension, type 2 diabetes, or hyperlipidemia
Blood sugar considerations For people without diabetes, blood sugar management during fasting on GLP-1 therapy is generally straightforward
Chromium supplements may have additive glucose-lowering effects when combined with semaglutide
Disease Prevention and Health Maintenance Regular use of L-Carnitine can contribute to the prevention of various metabolic and cardiovascular diseases
Treat this as a missed dose, and follow your prescriptions missed-dose instructions